Skip Navigation



ToxSci Advance Access published online on May 28, 2008
Toxicological Sciences, doi:10.1093/toxsci/kfn104
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
106/1/74    most recent
kfn104v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hegedus, C. M.
Right arrow Articles by Moore, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegedus, C. M.
Right arrow Articles by Moore, L. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Decreased Urinary Beta Defensin-1 Expression as a Biomarker of Response to Arsenic

Christine M. Hegedus*, Christine F. Skibola*,§, Marcella Warner*, Danica R. Skibola*, David Alexander*, Sophia Lim*, Nygerma Dangleben*, Luoping Zhang*, Michael Clark*, Ruth M. Pfeiffer{dagger}, Craig Steinmaus{ddagger}, Allan H. Smith*, Martyn T. Smith* and Lee E. Moore{dagger}

* School of Public Health, University of California, Berkeley, CA 94720-7356 {dagger} Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892-7420 {ddagger} Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA 94612

§ Corresponding author: Christine F. Skibola, Ph.D., School of Public Health, Division of Environmental Health Sciences, Room 237A, B84 Hildebrand Hall MC7356, University of California, Berkeley, California 94720-7356. (510) 643-5041 tel / (510) 642-0427 fax

Received February 28, 2008; revision received May 20, 2008; accepted May 21, 2008


  Abstract

Ingestion of arsenic (As) through contaminated drinking water results in increased risks of skin, lung, kidney, and bladder cancers. Due to its association with kidney and bladder cancers, we hypothesized that analysis of the urinary proteome could provide insight into the mechanisms of As toxicity. Urine from participants in a cross-sectional As biomarker study conducted in Nevada, classified as having either high (≥100 µg total urinary As/L) or low exposure (<100 µg total urinary As/L) was analyzed by surface enhanced laser desorption/ionization time-of-flight mass spectrometry. Two polypeptides, 2.21 and 4.37 kD, were significantly decreased in the high exposure group (p<0.05) and were limited to men when stratified by sex. To replicate these findings, urine from participants in a second As study in Chile was analyzed and results confirmed the decrease of the 4.37 kD polypeptide as well as a 4.76 kD polypeptide among highly exposed men. These peaks were identified and confirmed as human β-defensin-1 (HBD-1) peptides. In a separate in vitro experiment, gene expression analysis of As-treated cell lines demonstrated reduced HBD1 mRNA confirming that the observed decrease in HBD-1 resulted from As exposure. HBD-1 is an antimicrobial peptide constitutively expressed in multiple tissues including epithelial cells of the respiratory and urogenital systems. Recent studies support its role as a tumor suppressor gene for urological cancers suggesting that decreased HBD-1 levels may play a role in the development of cancers associated with As exposure. Further studies are warranted to investigate the role of HBD-1 in As-related toxicity.

Key Words: arsenic; human beta defensin-1; proteomics; SELDI-TOF MS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.